• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Screening and purification of Shiga-like (Vero)toxin inhibitors

Research Project

Project/Area Number 09470073
Research Category

Grant-in-Aid for Scientific Research (B)

Allocation TypeSingle-year Grants
Section一般
Research Field Bacteriology (including Mycology)
Research InstitutionChiba Unibersity

Principal Investigator

NODA Masatoshi  Chiba Unibersity, School of Medicine, Chairman snd Professor, 医学部, 教授 (60164703)

Co-Investigator(Kenkyū-buntansha) MIYAKE Masami  Chiba University, School of Medicine, Research Assistant, 医学部, 助手 (10251175)
Project Period (FY) 1997 – 1998
Project Status Completed (Fiscal Year 1998)
Budget Amount *help
¥4,000,000 (Direct Cost: ¥4,000,000)
Fiscal Year 1998: ¥4,000,000 (Direct Cost: ¥4,000,000)
KeywordsShiga-like(Vero)toxin / virulence factor / O157 : H7 / Vero cells / lethal toxicity / fluid accumulation / rabbit ileal loop / 白子蛋白 / O157:H7 / O157 / Shiga-like toxin / 抗VT活性 / 大黄 / 桂皮
Research Abstract

Shiga-like (Vero) toxin, a heterooligomeric protein composed of one A and five B subunit, is a major virulence factor produced by enterohemorrhagic Escherichia coli O157 : H7. The severe bloody diarrhea observed in E.coli 0157 patients is mediated by Shiga-like toxin- catalyzed cleavage of N-glycosidic bond of the adenosine at 4,324 from the 5'-terminal of the 28S ribosomal RNA of 60S ribosomal subunit in the target cells. We have investigated inhibitors of Shiga-like toxin, of natura1 origin, and found a candidate that inhibits the cytotoxicity of the toxin to Vero cells and a certain line of HeLa cells, lethal toxicity to mice and other small experimental animals, and bloody fluid accumulation in the rabbit ileal loop.

Report

(3 results)
  • 1998 Annual Research Report   Final Research Report Summary
  • 1997 Annual Research Report
  • Research Products

    (21 results)

All Other

All Publications (21 results)

  • [Publications] Yamamoto S., Noda M., et al: "Mutants in the ADP-ribosyltransferase cleft of cholera toxin lack diarrheagenicity but retain adjuvanticity." J.Exp.Med.185. 1203-1210 (1997)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1998 Final Research Report Summary
  • [Publications] Yamamoto S., Noda M., et al.: "A nontoxic mutant of cholera toxin elicits Th2-type responses for enhanced mucosal immunity." Proc.Natl.Acad.Sci.84. 5267-5272 (1997)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1998 Final Research Report Summary
  • [Publications] Suzuki K., Noda M., et al.: "The contribution of endogenous mono-ADP-ribosylation to kindling-induced epileptogenesis." Brain Research. 745. 109-113 (1997)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1998 Final Research Report Summary
  • [Publications] Yamaoka J., Noda M., et al.: "Loss of biological activity due to Glu→Arg mutation at residue 11 of the B subunit of cholera toxin." Microbial Pathogenesis. 23. 297-302 (1997)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1998 Final Research Report Summary
  • [Publications] Kuwabara S., Noda M., et al.: "IgG-Anti-GM1 antibody is associated with reversible conduction failure and axonal degeneration in guillain-barre syndrome." Annals of Neurology. 44. 202-208 (1998)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1998 Final Research Report Summary
  • [Publications] Nomura F., Noda M., et al.: "Long-term alcohol effects on hepatic phosphoglucomutase activities in relation to posttranslational modification of the protein." Alcohol Clin.Exp.Res.22. 121S-124S (1998)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1998 Final Research Report Summary
  • [Publications] 野田公俊: "毒素産生菌とその感染症. ; 毒素産生菌感染症の基礎と臨床" 医薬ジャーナル社, 11 (1998)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1998 Final Research Report Summary
  • [Publications] Yamamoto S., Noda M., et al.: "Mutants in the ADP-ribosyltransferase cleft of cholera toxin lack diarrheagenicity but retain adjuvanticity.." J.Exp.Med.185. 1203-1210 (1997)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1998 Final Research Report Summary
  • [Publications] Yamamoto S., Noda M., et al.: "A nontoxic mutant of cholera toxin elicits Th2-type restonses for enhanced mucosal immunity." Proc.Natl. Acad.Sci.94. 5267-5272 (1997)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1998 Final Research Report Summary
  • [Publications] Suzuki k., Noda M., et al.: "The contribution of endogenous mono-ADP-ribosylation to kindling-induced epileptogenesis." Brain Research. 745. 109-113 (1997)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1998 Final Research Report Summary
  • [Publications] Yamaoka J., Noda M., et al.: "Loss of biological activity due to Glu*Arg mutation at residue 11 of the B subunit of cholera toxin." Microbial Pathogenesis.23. 297-302 (1997)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1998 Final Research Report Summary
  • [Publications] Kuwabara S., Noda M., et al.: "IgG anti-GM1 antibody is associated with reversible conduction failure and axonal degeneration in guillain-barre syndrome." Annals of Neurology. 44. 202-208 (1998)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1998 Final Research Report Summary
  • [Publications] Nomura F., Noda M., et al.: "Long-term alcohol effects on hepatic phosphoglucomutase activites in relation to posttranslational modification of the protein." Alcohol Clin.Exp.Res.22. 121S-124S (1998)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1998 Final Research Report Summary
  • [Publications] Yamamoto S.,et al.: "Mutants in the ADP-ribosyltransferase cleft of cholera toxin lack diarrheagenicity but retain adjuvanticity." J.Exp.Med.185. 1203-1210 (1997)

    • Related Report
      1998 Annual Research Report
  • [Publications] Yamamoto S.,et al.: "A nontoxic mutant of cholera toxin elicits Th2-type responses for enhanced mucosal immunity." Proc.Natl.Acad.Sci.94. 5267-5272 (1997)

    • Related Report
      1998 Annual Research Report
  • [Publications] Suzuki K.,et al.: "The contribution of endogenous mono-ADP-ribosylation to kindling-induced epileptogenesis." Brain Research. 745. 109-113 (1997)

    • Related Report
      1998 Annual Research Report
  • [Publications] Yamaoka J.,et al.: "Loss of biological activity due to Glu→Arg mutation at residue 11 of the B subunit of cholera toxin." Microbial Pathogenesis. 23. 297-302 (1997)

    • Related Report
      1998 Annual Research Report
  • [Publications] Kuwabara S.,et al.: "IgG Anti-GM1 antibody is associated with reversible conduction failure and axonal degeneration in guillain-barre syndrome." Annals of Neurology. 44. 202-208 (1998)

    • Related Report
      1998 Annual Research Report
  • [Publications] nomura F.,et al.: "Long-term alcohol effects on hepatic phosphoglucomutase activities in relation to posttranslational modification of the protein." Alcohol Clin.Exp.Res.22. 121S-124S (1998)

    • Related Report
      1998 Annual Research Report
  • [Publications] Yamamoto,S., Noda,M.et al.: "Mutants in the ADP-ribosyltransferase cleft of cholera toxin lack diarrheagenicity but retain adjuvantiocity." J.Exp.Med.185. 1203-1210 (1997)

    • Related Report
      1997 Annual Research Report
  • [Publications] Yamamoto,S., Noda,M.et al.: "A nontoxic mutant of cholera toxin elicits Th2-type responses for enhanced mucosal immunity." Proc.Natl.Acad.Sci.USA. 94. 5267-5272 (1997)

    • Related Report
      1997 Annual Research Report

URL: 

Published: 1998-04-01   Modified: 2016-04-21  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi